[ 1 ] O’Brien TJ, Tanimoto H, Konishi I, et al. More than 15 years of CA125: what is known about the antigen, its structure and its function[J]. Int J Biol Markers, 1998, 13(4): 188-195.
[2]
[ 2 ] D’Aloia A, Faggiano P, Aurigemma G, et al. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis[J]. J Am Coll Cardiol, 2003, 41(10): 1805-1811.
[3]
[ 3 ] Sevinc A, Buyukberger S, Sari R, et al. Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids[J]. Gynecol Oncol, 2000, 77(2): 254-257.
[ 8 ] Yilmaz MB, Zorlu A, Dogan OT, et al. Role of CA-125 in identification of right ventricular failure in chronic obstructive pulmonary disease[J]. Clin Cardiol, 2011, 34(4): 244-248.
[6]
[ 7 ] Kouris NT, Zacharos ID, Kontogianni DD, et al. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters[J]. Eur J Heart Fail, 2005, 7(2): 199-203.
[7]
[ 9 ] Uz O, Kardesoglu E, Tas D, et al. CA-125 Level Is Associated with right ventricular echocardiographic parameters in patients with COPD[J]. South Med J, 2011, 104(9): 624-628.
[8]
Duman C, Ercan E, Tengiz I, et al. Elevated serum CA 125 levels in mitral stenotic patients with heart failure[J]. Cardiology, 2003, 100(1): 7-10.
